Fig. 2From: New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationEfficiency frontiers (discounted total costs [US$ billions] per disability-adjusted life year (DALY) averted) for Policy Scenarios for each vaccine productBack to article page